In the last 7 days
7th Circ. Mulls Expiration Date Of Teva, Eli Lilly Patent Deal Law36018:05 11-Feb-26
GSK, Teva quietly settle Coreg 'skinny label' dispute after long legal back-and-forth FiercePharma11:46 11-Feb-26
GSK, Teva End High-Stakes ’Skinny Label’ Fight Over Coreg Patent Bloomberg Law11:15 11-Feb-26
GSK, Teva Settle 'Skinny Label' Heart Medication Suit Law36020:21 10-Feb-26
Will Forte details grueling return to SNL for Glen Powell's MacGruber sketch: 'It really was like the old days' Entertainment Weekly12:14 7-Feb-26
In the last month
Teva Wins Jury Verdict in First Paragard IUD Bellwether Trial Bloomberg Law15:55 5-Feb-26
Teva Wins 1st Paragard IUD Bellwether Trial Law36018:55 4-Feb-26
Teva Fights Class Cert. Bid In Effexor Antitrust Case Law36018:25 4-Feb-26
Notable ETF Inflow Detected - IDEV, SPOT, SE, TEVA Nasdaq11:20 3-Feb-26
Mon: TASE opens February with strong gains Globes00:20 3-Feb-26
Teva Israel, Health Ministry issue recall for Nutrilon Phase 1, Nutrilon AR baby formula Jerusalem Post17:25 30-Jan-26
Teva Tries To Spike Paragard Trial Claims, Punitive Damages Law36018:48 29-Jan-26
Sandoz, Teva Beat Malicious Prosecution Claims, For Now Law36017:16 29-Jan-26
TEVA's Q4 Earnings Beat, Branded Drugs Drive Revenue Growth Zacks12:26 29-Jan-26
What Makes Teva Pharmaceuticals (Teva) a Successful Brand? Yahoo! US10:16 29-Jan-26
After a threefold rally, Teva faces its next test CTech07:44 29-Jan-26
Teva Allowed New Mifepristone Claim But Not New Defendant Law36020:13 28-Jan-26
Teva Pharmaceutical Q4 profit gains as branded drugs aid transition from generics Yahoo! US12:51 28-Jan-26
Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook Benzinga12:27 28-Jan-26
Teva, after third straight year of growth, expects downturn in 2026 FiercePharma11:27 28-Jan-26
Here's Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock Zacks10:45 28-Jan-26
Teva Pharmaceutical Industries (TEVA) Reports Q4 Earnings: What Key Metrics Have to Say Zacks10:35 28-Jan-26
Teva sees lower revenue and profit in 2026 Globes08:13 28-Jan-26
Medincell - Uzedy®: Net Sales Increased from $117M in 2024 to $191M in 2025 (+63%) Business Wire (Press Release)08:07 28-Jan-26
Teva’s 2026 forecast disappoints despite strong finish to 2025 CTech08:05 28-Jan-26
Investors Say Teva Can't Get Early Win in Price-Fixing Suit Law36018:27 27-Jan-26
Earnings Preview For Teva Pharmaceutical Indus Benzinga11:11 27-Jan-26
Teva taps ‘SNL’ alum Will Forte to join Huntington’s disease awareness push FiercePharma08:08 27-Jan-26
Novo Nordisk sued in US for allegedly monopolizing diabetes drug Victoza The Economic Times20:42 23-Jan-26
What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q4 Earnings Zacks10:20 23-Jan-26
Assessing Teva (TEVA) Valuation As Guidance Driven Momentum Lifts Long Term Profit Expectations Simply Wall St06:28 23-Jan-26
Teva's Inconsistent Args In IUD Trial 'Troubling,' Judge Says Law36017:22 21-Jan-26
J.P. Morgan: Teva Targets Long-Term Value Over Fast Uptake For Long-Acting Olanzapine Scrip Pharma Intelligence13:35 16-Jan-26
Teva’s migraine biologic Ajovy marks phase III progress for paediatric patients European Pharmaceutical Review10:48 16-Jan-26
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now? Zacks09:55 16-Jan-26
JPM26: What’s in a biopharma? CEO says Teva has the goods FiercePharma09:00 16-Jan-26
Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy? Zacks11:00 15-Jan-26
Teva Can't Visit 11th Circ. Ahead Of 1st Paragard Bellwether Law36021:55 13-Jan-26
Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial Benzinga11:22 13-Jan-26

      
            
      
    view more headlines
   
      
      
      
11 Feb 18:05
   
Teva News

NewsNow brings you the latest news from the world’s most trusted sources on Teva. NewsNow aims to be the world’s most accurate and comprehensive Teva news aggregator, bringing you the latest headlines automatically and continuously 24/7.
Teva

Latest News

Teva News

Pharmaceuticals Top Stories

Business Top Stories
